GLI1 and systemic sclerosis: We and others have shown that GLI1 and GLI2 are upregulated in SSc skin and fibroblasts [5] and SHH pathway activation plays an important role in the pathogenesis of tissue fibrosis both in scleroderma and sclerotic graft versus host disease (GVHD) [5, 6].